The mechanism of action of fluorouracil (5-FU) and the oral fluoropyrimidin
es and the importance of biochemical modulation and inhibition of dihydropy
rimidine dehydrogenase for oral application of the prodrugs of 5-FU are dis
cussed. The regulation of thymidylate synthase, as well as its roles as a t
arget for antineoplastic activity and in drug resistance, are also mentione
d. The more downstream events of 5-FU action and their implication in 5-FU
resistance, whit the possible involvement of the Fas/FasL system and the pr
oteins associated with apoptosis regulation, are highlighted. Also discusse
d is the suggestion that the oral 5-FU prodrug tegafur and uracil (UFT) and
its metabolites function as an angiogenesis inhibitor.